Table 1.
The age, gender and ethnic background of patients across all categories are shown.
Figure 1.
Serum GFAP Level (pg/mL) Across All Groups, Shown in Tukey Box Plot.
Tukey box plot showing the median, 25th percentile and 75th percentile of serum GFAP level measurements in each group. The 5th and 95th percentile of groups 1 and 2 are also shown.
Figure 2.
Time in Days Following the Onset of Acute Optic Neuritis, When Serum GFAP Measurements Were Acquired, Versus the Serum GFAP Level in pg/mL.
Although many patients' serum was tested within 50 days of onset, their serum samples were collected up to 210 days following the onset of acute optic neuritis.
Table 2.
Descriptive statistics of serum GFAP measurements (pg/mL) in patients across all categories3 are shown.
Figure 3.
Serum GFAP Level (pg/mL) Measurements in Patients without Extra-Optic Nerve Disease (AQP4+ON, ‘RION’ and ‘CRION’ Groups).
Tukey box plot showing the median, 25th percentile and 75th percentile of serum GFAP level measurements in each group.
Table 3.
Descriptive statistics of serum GFAP measurements (pg/mL) in patients without optic nerve disease1 are shown.